HK · Healthcare

Uni-Bio Science Group Ltd (0690)

Biotechnology

Uni-Bio Science Group Ltd (0690) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $519.50M, P/E ratio is 4.35, net margin is 15.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 0690

Market cap
$519.50M
P/E ratio
4.35
Gross profit (TTM)
$487.56M
Net margin
15.9%

Uni-Bio Science Group Ltd (0690) — FAQ

What is Uni-Bio Science Group Ltd's market cap?

Uni-Bio Science Group Ltd (0690) has a reported market cap of $519.50M (data as of 2026-05-21).

What is 0690's P/E ratio?

The price-to-earnings (P/E) ratio for Uni-Bio Science Group Ltd (0690) is 4.35 (data as of 2026-05-21).

Does Uni-Bio Science Group Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Uni-Bio Science Group Ltd (0690). Check the MyAverix Finance app for the latest dividend data.

What sector is Uni-Bio Science Group Ltd in?

Uni-Bio Science Group Ltd (0690) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 0690 listed on?

0690 is listed on HK.

What is Uni-Bio Science Group Ltd's net margin?

Uni-Bio Science Group Ltd (0690) reports a net margin of 15.9% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play